Anti-Myosin Light Chain 2 抗体 [EPR3741] (ab92721)

ab92721 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab92721 は 5 報の論文で使用されています。

  • Yu ZY  et al. RhoA/ROCK Signaling and Pleiotropic a1A-Adrenergic Receptor Regulation of Cardiac Contractility. PLoS One 9:e99024 (2014). WB ; Mouse . PubMed: 24919197
  • Weterman MA  et al. Recessive MYL2 mutations cause infantile type I muscle fibre disease and cardiomyopathy. Brain 136:282-93 (2013). IHC-Fr ; Human . PubMed: 23365102
  • Carberry S  et al. Comparative proteomic analysis of the contractile-protein-depleted fraction from normal versus dystrophic skeletal muscle. Anal Biochem N/A:N/A (2013). PubMed: 23954569
  • Monasky MM  et al. p21-activated kinase improves cardiac contractility during ischemia-reperfusion concomitant with changes in troponin-T and myosin light chain 2 phosphorylation. Am J Physiol Heart Circ Physiol 302:H224-30 (2012). WB ; Mouse . PubMed: 22037191
  • Wang Y  et al. Cardiac myosin isoforms exhibit differential rates of MgADP release and MgATP binding detected by myocardial viscoelasticity. J Mol Cell Cardiol : (2012). PubMed: 23123290

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"